Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 5 | 5 |
Avg. Estimate | 0 | 0 | 0.01 | 0.02 |
Low estimate | 0 | 0 | -0.06 | -0.03 |
High estimate | 0 | 0 | 0.13 | 0.13 |
Year ago EPS | N/A | N/A | -0.09 | 0.01 |
Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 4 | 0 | 4 | 4 |
Avg. Estimate | 121.48M | N/A | 121.48M | 122.14M |
Low estimate | 116.1M | N/A | 116.1M | 109.17M |
High estimate | 129.57M | N/A | 129.57M | 130.53M |
Year ago sales | 133.79M | N/A | 133.79M | 121.48M |
Sales growth (year/est) | -9.20% | N/A | -9.20% | 0.50% |
Earnings history | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
---|---|---|---|---|
Est. EPS | N/A | N/A | N/A | N/A |
Actual EPS | N/A | N/A | N/A | N/A |
Difference | N/A | N/A | N/A | N/A |
Surprise % | N/A | N/A | N/A | N/A |
EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0.01 | 0.02 |
7 days ago | 0 | 0 | 0.01 | 0.02 |
30 days ago | 0 | 0 | 0.01 | 0.02 |
60 days ago | 0 | 0 | 0.02 | 0.03 |
90 days ago | 0 | 0 | 0.01 | 0.02 |
EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | PHAR.L | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | 111.10% | N/A | N/A | N/A |
Next year | 100.00% | N/A | N/A | N/A |
Next 5 years (per annum) | -221.70% | N/A | N/A | N/A |
Past 5 years (per annum) | -35.34% | N/A | N/A | N/A |